Female infertility is a complex medical condition that may develop due to hormonal imbalance, reduced ovarian reserve, poor endometrial receptivity, impaired microcirculation, chronic inflammation, or age-related decline in reproductive function. One of the most challenging diagnoses in reproductive medicine is ovarian insufficiency, sometimes referred to as diminished ovarian reserve or premature ovarian aging. In such cases, the ovaries gradually lose their ability to produce viable follicles, hormone levels become unstable, and the endometrium often becomes thin and poorly receptive for implantation.
Traditional fertility treatments usually include hormonal stimulation, IVF protocols, platelet-rich plasma (PRP) therapy, and endometrial stimulation procedures. However, in many patients, especially after the age of 38–40, these treatments may not produce the expected results because they do not restore the biological environment of the ovaries and endometrium. Instead, they attempt to stimulate tissues that are already biologically depleted.
Regenerative medicine approaches infertility differently. Rather than forcing the ovaries to work harder, regenerative therapy aims to restore the microenvironment of the ovaries, improve blood supply, reduce inflammation, and support cellular regeneration processes, creating conditions in which reproductive function can partially recover.
This clinical case describes the regenerative treatment of a patient with ovarian insufficiency and thin endometrium, and the clinical outcomes that followed.
Patient Profile
The patient, Dina, was a 39-year-old woman who had been struggling with infertility for several years. She had never had a successful pregnancy despite multiple fertility treatments. Her diagnosis included diminished ovarian reserve, thin endometrium, and poor ovarian response to hormonal stimulation.
For several years, Dina underwent various fertility treatments, including hormonal stimulation protocols, intrauterine procedures, and platelet-rich plasma (PRP) therapy. Although some temporary changes were observed after these treatments, none resulted in stable improvement or pregnancy.
By the time she sought regenerative therapy, Dina was emotionally exhausted and had been told that her chances of pregnancy with her own eggs were extremely low.
Clinical Status Before Therapy
At the time of admission, Dina underwent a comprehensive hormonal, biochemical, and ultrasound evaluation.
Her clinical results were consistent with ovarian insufficiency:
- AMH (Anti-Müllerian Hormone): 0.3 ng/ml
- FSH: 18–20 IU/L
- LH: 9 IU/L
- Estradiol: low-normal
- Progesterone in luteal phase: low
- Endometrial thickness: 4.5–5 mm
- Poor ovarian follicular activity on ultrasound
- Reduced ovarian blood flow on Doppler imaging
These findings indicated that the ovaries were functioning at a significantly reduced level, and the endometrium was too thin to support implantation.
From a clinical perspective, the prognosis in such cases is usually considered poor, particularly after unsuccessful hormonal stimulation and PRP therapy. Many patients in this situation are advised to consider donor eggs.
However, regenerative therapy was considered because the goal was not only stimulation, but restoration of ovarian and endometrial microenvironment.
Why Previous Treatments Did Not Work
Understanding why previous treatments failed is essential in infertility cases like Dina’s.
Hormonal stimulation works by forcing the ovaries to produce follicles through high doses of gonadotropins. However, if the ovarian environment has poor blood supply, chronic inflammation, fibrosis, or mitochondrial dysfunction, the follicles simply cannot develop properly, regardless of hormone levels.
In Dina’s case, the main problems were not only hormonal but microvascular and cellular:
- Reduced blood flow to the ovaries
- Poor oxygenation of ovarian tissue
- Thin and poorly vascularized endometrium
- Reduced follicular microenvironment quality
- Possible mitochondrial dysfunction in ovarian cells
- Chronic low-grade inflammation
- Fibrotic changes in endometrial tissue
PRP therapy can sometimes stimulate tissue repair, but its effect depends on the tissue’s ability to respond. If the stem cell niche and microcirculation are impaired, PRP alone may not be sufficient.
Therefore, previous treatments attempted stimulation without regeneration, which explains why the results were temporary or absent.
CONTACT OUR DOCTOR
Regenerative Treatment Protocol
Dina underwent a 3-day regenerative therapy program designed specifically for ovarian and endometrial regeneration.
The protocol included a combination of:
- Human mesenchymal stem cells (hMSCs)
- Endometrial regenerative cells
- Microvascular endothelial cells
- Stem cell–derived exosomes
This combination was selected because infertility related to ovarian insufficiency and thin endometrium is not caused by a single factor. It involves vascular, hormonal, inflammatory, and cellular regeneration problems simultaneously.
Why This Combination Was Used
Human mesenchymal stem cells play a central role in regenerative therapy due to their ability to reduce inflammation, release growth factors, stimulate tissue repair, and improve cellular communication. These cells do not replace ovarian tissue directly but restore the environment in which ovarian cells function.
Endometrial cells were used to specifically support the regeneration of the uterine lining. The endometrium is a highly dynamic tissue that must regenerate every cycle, and when its regenerative capacity is impaired, implantation becomes impossible. Endometrial regenerative cells help restore endometrial thickness, vascularization, and receptivity.
Microvascular endothelial cells were included to improve blood supply to both the ovaries and the endometrium. Blood flow is one of the most important factors in reproductive function because follicles require oxygen, nutrients, and hormonal signaling delivered through the microvascular network.
Exosomes played a signaling role. These nano-sized vesicles contain growth factors, mRNA, and regulatory molecules that help activate tissue repair, improve cellular communication, and stimulate regeneration at a molecular level.
Method of Administration
The therapy was administered both locally and intravenously over three days.
Local administration targeted the ovaries and endometrium directly, ensuring that regenerative cells reached the areas where tissue repair was required.
Intravenous administration supported systemic effects, including immune modulation, improved microcirculation, and overall metabolic and hormonal balance.
Clinical Outcomes and Biological Changes After Therapy
The changes observed after regenerative therapy occurred gradually over several months, which is typical for regenerative treatments because they work by rebuilding tissue environment rather than producing immediate pharmacological effects.
Hormonal Improvements
Within the first 3–4 months after therapy, Dina’s hormonal profile began to change:
- AMH increased from 0.3 → 0.9 ng/ml
- FSH decreased from 19 → 9 IU/L
- LH normalized
- Estradiol levels improved
- Progesterone in luteal phase increased
These changes indicated improved ovarian activity and follicular function.
Endometrial Changes
One of the most significant improvements was observed in the endometrium.
Before therapy, endometrial thickness was approximately 4.5–5 mm, which is considered insufficient for implantation.
After therapy:
- Endometrial thickness increased to 7.5–8.2 mm
- Improved endometrial vascularization (confirmed by Doppler imaging)
- Improved endometrial structure and receptivity
This improvement was critical for successful implantation.
Microcirculation and Tissue Metabolism
Doppler ultrasound showed improved ovarian and uterine blood flow by approximately 40–50%, indicating restoration of microvascular circulation. Improved blood flow means better oxygenation, better nutrient delivery, and improved hormonal signaling to reproductive tissues.
Biochemical markers also showed improvement in metabolic and inflammatory parameters, suggesting improved overall tissue environment.
Clinical Outcome: Pregnancy and Birth
Approximately several months after therapy, Dina underwent a fertility cycle, and this time the conditions were significantly different from previous attempts.
Her ovaries responded better, the endometrium reached adequate thickness, and implantation was successful.
The pregnancy progressed normally, and Dina later gave birth to a healthy baby girl.
For the patient, this outcome was not just a medical success — it was the result of restoring biological function that had previously been considered lost.
Clinical Interpretation
This case demonstrates an important concept in reproductive medicine:
Infertility in many women over 35–40 is not only a hormonal problem — it is a microenvironment problem, involving blood supply, inflammation, cellular communication, mitochondrial function, and tissue regeneration capacity.
Regenerative therapy works not by forcing the ovaries to function, but by restoring the conditions under which they can function again.
This includes:
- Improving ovarian microcirculation
- Restoring endometrial receptivity
- Reducing inflammation
- Supporting follicular environment
- Improving mitochondrial activity
- Enhancing cellular communication through exosomes
When these conditions improve, hormonal balance and reproductive function often improve as a secondary effect.
This clinical case illustrates how regenerative medicine can offer new possibilities for patients with ovarian insufficiency and thin endometrium, especially after unsuccessful traditional treatments.
By addressing the underlying biological environment — vascular, cellular, metabolic, and inflammatory factors — regenerative therapy may help restore reproductive function and improve the chances of pregnancy.
For patients like Dina, the most important outcome is not only improved laboratory values or ultrasound findings, but the final result — the birth of a child after years of infertility.
This represents not just treatment, but restoration of biological potential.
Explore one more success review:
FREE CONSULTATION
